- Home
- RKDA vs RDHL Comparison
RKDA vs RDHL Comparison
Compare RKDA & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RKDA | RDHL |
|---|---|---|
| Founded | 2002 | 2009 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8M | 3.8M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | RKDA | RDHL |
|---|---|---|
| Price | $3.66 | $1.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.0K | ★ 69.2K |
| Earning Date | 11-07-2025 | 09-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $5,173,000.00 | ★ $9,550,000.00 |
| Revenue This Year | $21.31 | $381.91 |
| Revenue Next Year | $28.33 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 12.31 | ★ 157.62 |
| 52 Week Low | $2.53 | $1.01 |
| 52 Week High | $6.71 | $7.00 |
Technical Indicators
Market Signals| Indicator | RKDA | RDHL |
|---|---|---|
| Relative Strength Index (RSI) | 47.74 | 47.48 |
| Support Level | $3.50 | $1.15 |
| Resistance Level | $3.80 | $1.24 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 43.24 | 33.66 |
Price Performance
Historical ComparisonAbout RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.